| Literature DB >> 28672791 |
Julia K Bird1, Rachel A Murphy2, Eric D Ciappio3, Michael I McBurney4.
Abstract
Certain population sub-groups in the United States are vulnerable to micronutrient malnutrition. Nationally representative data from the National Health and Nutrition Examination Survey (NHANES) describing the biochemical status of vitamins A, B6, B12, C, D, E, folate, and anemia, were aggregated to determine the overall risk of multiple concurrent deficiencies in U.S. children and adults (n = 15,030) aged >9 years. The prevalence of deficiency risk according to socio-demographic, life-stage, dietary supplement use, and dietary adequacy categories was investigated. Thirty-one percent of the U.S. population was at risk of at least one vitamin deficiency or anemia, with 23%, 6.3%, and 1.7% of the U.S. population at risk of deficiency in 1, 2, or 3-5 vitamins or anemia, respectively. A significantly higher deficiency risk was seen in women (37%), non-Hispanic blacks (55%), individuals from low income households (40%), or without a high school diploma (42%), and underweight (42%) or obese individuals (39%). A deficiency risk was most common in women 19-50 years (41%), and pregnant or breastfeeding women (47%). Dietary supplement non-users had the highest risk of any deficiency (40%), compared to users of full-spectrum multivitamin-multimineral supplements (14%) and other dietary supplement users (28%). Individuals consuming an adequate diet based on the Estimated Average Requirement had a lower risk of any deficiency (16%) than those with an inadequate diet (57%). Nearly one-third of the U.S. population is at risk of deficiency in at least one vitamin, or has anemia.Entities:
Keywords: NHANES; deficiency; dietary adequacy; dietary supplement; multivitamin-mineral; nutritional epidemiology; nutritional status
Mesh:
Substances:
Year: 2017 PMID: 28672791 PMCID: PMC5537775 DOI: 10.3390/nu9070655
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Deficiency risk criteria and risk of deficiency in individual vitamins or anemia.
| Nutritional Biomarker | Deficiency Risk Criteria | Proportion Biochemically Deficient 2003–2004 | Proportion Biochemically Deficient 2005–2006 | Proportion Biochemically Deficient 2003–2006 | |||
|---|---|---|---|---|---|---|---|
| % | SE | % | SE | % | SE | ||
| Vitamin A | Serum retinol <20 µg/dL [ | 0.28 | 0.65 | 0.25 | 0.84 | 0.26 | 0.05 |
| Vitamin B6 | PLP <20 nmol/L [ | 20 * | 1.4 | 11 * | 0.76 | 16 | 0.87 |
| Vitamin B12 | Serum vitamin B12 <200 pg/mL or MMA >0.271 µmol/L [ | 7.5 * | 0.70 | 2.6 * | 0.30 | 5.0 | 0.44 |
| Folate | Red blood cell folate <95 ng/mL or serum folate <2 ng/mL [ | 0.37 | 0.10 | 0.18 | 0.40 | 0.27 | 0.05 |
| Vitamin C | Serum ascorbic acid <0.2 mg/dL [ | 7.5 | 0.99 | 4.9 | 0.59 | 6.2 | 0.59 |
| Vitamin D | 25-hydroxyvitamin D <12 ng/mL [ | 7.9 | 1.2 | 9.8 | 1.2 | 8.9 | 0.83 |
| Vitamin E | Alpha-tocopherol <500 µg/dL [ | 0.75 | 0.15 | 0.66 | 0.09 | 0.70 | 0.08 |
| Anemia | Hemoglobin <13 g/dL (men ≥15 years) or <12 (women ≥15 years, adolescents 12–14 years) or <11 g/dL | 3.9 | 0.41 | 4.6 | 0.37 | 4.3 | 0.28 |
Data are from NHANES 2003–2006 representative of the U.S. population, aged ≥9 years, based on biochemical indicators of nutrient deficiency. Abbreviations: PLP, pyridoxal-5′-phosphate; MMA, methylmalonic acid; SE, standard error. * Cycles (2003–2004 or 2005–2006) differ significantly p < 0.05.
Risk of multiple vitamin deficiencies and/or anemia according to demographic characteristics.
| Characteristic | Deficient in 1 * | Deficient in 2 * | Deficient in 3–5 * | Not Deficient | |||||
|---|---|---|---|---|---|---|---|---|---|
| % | SE | % | SE | % | SE | % | SE | ||
| All participants | 13,225 | 23 | 0.78 | 6.3 | 0.49 | 1.7 | 0.18 | 69 | 1.2 |
| Cycle | |||||||||
| 2003–2004 | 6600 | 27 | 0.82 a | 7.2 | 0.64 | 1.9 | 0.29 | 63 | 1.4 a |
| 2005–2006 | 6625 | 19 | 1.1 b | 5.5 | 0.68 | 1.5 | 0.19 | 75 | 1.7 b |
| Sex | |||||||||
| Male | 6506 | 19 a | 1.1 | 4.6 a | 0.39 | 1.1 | 0.20 | 75 a | 1.4 |
| Female | 6719 | 26 b | 0.75 | 8.0 b | 0.64 | 2.3 | 0.29 | 64 b | 1.3 |
| Ethnicity † | |||||||||
| Mexican American | 3195 | 24 a | 1.4 | 5.4 a | 0.61 | 1.2 a | 0.30 | 69 a | 2.1 |
| Non-Hispanic White | 5647 | 20 a | 1.1 | 5.4 a | 0.46 | 1.3 a | 0.19 | 73 a | 1.4 |
| Non-Hispanic Black | 3432 | 36 b | 1.2 | 14 b | 0.81 | 5.1 b | 0.37 | 45 b | 1.7 |
| PIR (%) | |||||||||
| Low PIR, ≤1.85 | 5804 | 27 a | 0.92 | 9.8 a | 0.77 | 2.8 a | 0.27 | 60 a | 1.4 |
| Medium PIR, >1.85 and ≤3.5 | 3224 | 24 a | 0.91 | 6.1 a | 0.80 | 1.8 ab | 0.26 | 68 b | 1.3 |
| High PIR, >3.5 | 3570 | 18 b | 0.93 | 3.8 b | 0.43 | 0.82 b | 0.17 | 77 c | 1.1 |
| Education ‡ | |||||||||
| Less than high school | 2433 | 27 a | 1.1 | 11 a | 0.84 | 2.9 | 0.43 | 59 a | 1.6 |
| High school graduate | 2105 | 26 ab | 1.2 | 8.0 ab | 0.91 | 2.2 | 0.44 | 64 a | 1.5 |
| Some college/college graduate | 4043 | 21 b | 1.0 | 5.0 b | 0.47 | 1.5 | 0.23 | 72 b | 1.3 |
| BMI § | |||||||||
| Underweight | 280 | 23 ab | 2.6 | 10 | 2.4 | 8.4 | 1.7 | 58 ac | 4.1 |
| Normal weight | 2473 | 23 ab | 1.2 | 5.7 | 0.64 | 1.5 ab | 0.25 | 70 ab | 1.6 |
| Overweight | 2949 | 21 a | 0.90 | 5.4 | 0.51 | 0.98 a | 0.19 | 73 b | 1.1 |
| Obese | 2891 | 27 b | 1.3 | 9.4 | 0.88 | 2.8 b | 0.33 | 61 c | 1.8 |
| Pregnancy status | | |||||||||
| Positive | 574 | 33 | 3.2 | 14 | 2.7 | 4.9 | 1.3 | 48 | 4.8 |
| Negative | 4520 | 27 | 0.88 | 7.5 | 0.72 | 2.1 | 0.34 | 63 | 1.3 |
| Breastfeeding status ¶ | |||||||||
| Breastfeeding a child | 100 | 21 | 6.4 ** | 9.2 | 3.3 ** | 3.5 | 3.3 ** | 66 | 8.5 |
| Not breastfeeding | 269 | 35 | 4.7 | 15 | 3.2 | 3.9 | 1.6 ** | 47 | 4.9 |
The overall risk of vitamin deficiency or anemia was investigated according to age, gender, and life stage groups in Table 3. A risk of deficiency/anemia was most frequent in pregnant or breastfeeding women. Data are from NHANES 2003–2006 representative of the U.S. population, aged ≥9 years, based on biochemical indicators of nutrient deficiency. Abbreviations: PIR, poverty income ratio. * Risk of deficiency based on vitamins A, B6, B12, C, D, E, folate, or anemia. Different superscripts represent significant differences within demographical categories, p = 0.0125 using, for simplicity, the Bonferroni correction for five comparisons (the maximum number of sub-groups in the demographics categories included) and alpha = 0.05 for the entire table. † ”Other Hispanic” and “Other race” ethnicity categories not reported due to small sample size. ‡ Education status is restricted to adults aged 20 years and older. § Body mass index (BMI) categories are restricted to adults aged 20 years and older. | Percentages reflect proportion of women of childbearing potential: menstruating girls aged 8–11 and all women aged 12–59 years. ¶ Percentages reflect proportion of women 0 or 1 years postpartum at the time of the interview. ** Relative standard error >30%.
Age, gender, and life stage categories and risk of deficiency.
| Age, Gender and Life Stage Category | Deficient in 1 * | Deficient in 2 * | Deficient in 3–5 * | Not deficient | |||||
|---|---|---|---|---|---|---|---|---|---|
| % | SE | % | SE | % | SE | % | SE | ||
| 9–13 years, male & female | 1734 | 15 b | 1.4 | 1.5 ab | 0.36 | 0.06 a**‡ | 0.04 | 83 ab | 1.6 |
| 14–18 years, male | 1242 | 18 b | 1.7 | 2.2 a | 0.65 | 0.13 ab**‡ | 0.08 | 80 a | 1.9 |
| 14–18 years, female | 1107 | 26 ab | 1.9 | 5.3 abc | 0.89 | 0.98 abcd | 0.23 | 68 bcd | 2.2 |
| 19–50 years, male | 2442 | 20 b | 1.3 | 3.9 ab | 0.36 | 0.70 abc | 0.23 | 76 ab | 1.5 |
| 19–50 years, female | 2150 | 30 a | 1.0 | 8.5 cd | 0.89 | 2.5 d | 0.43 | 59 d | 1.6 |
| 51–70 years, male & female | 2347 | 21 b | 1.2 | 7.4 bcd | 0.90 | 2.0 cd | 0.27 | 70 abc | 1.7 |
| 71+ years, male & female | 1540 | 23 b | 1.0 | 9.5 cd | 0.93 | 3.4 d | 0.48 | 64 cd | 1.7 |
| Pregnant or breastfeeding | 683 | 30 ab | 3.3 | 13 d | 2.2 | 4.6 d | 1.5 | 53 d | 4.3 |
Data are from NHANES 2003–2006 representative of the U.S. population, aged ≥9 years, based on biochemical indicators of nutrient deficiency. * Risk of deficiency based on vitamins A, B6, B12, C, D, E, folate, or anemia. Different superscripts represent significant differences between life stage categories, p < 0.00625 using Bonferroni correction for eight sub-groups and alpha = 0.05. ** Relative standard error >30%. ‡ Comparison made using Clopper–Pearson (exact) confidence interval.
Percentage at risk of deficiency of individual vitamins, or anemia, by age, gender, and life stage categories.
| Age, Gender, and Life Stage Category | Serum Retinol <20 µg/dL | PLP <20 nmol/L | Vitamin B12 <200 pg/mL or MMA >0.271 µmol/L | Serum Folate <2 ng/mL or RBC Folate <95 ng/mL | Vitamin C <0.2 mg/dL | Vitamin D <12 ng/mL | Vitamin E <500 µg/dL | Anemia and MCV <95 fL |
|---|---|---|---|---|---|---|---|---|
| 9–13 years, male & female | 0.41 (0.083, 1.2) *‡ | 9.4 (5.8, 12.9) | 1.3 (0.30, 3.5) *‡ | 0.21 (0.011, 1.0) *‡ | 1.1 (0.33, 2.6) *‡ | 4.0 (2.2, 5.8) | 1.4 (0.3, 2.5) | 1.3 (0.5, 2.2) |
| 14–18 years, male | 0.034 (0, 0.53) *‡ | 5.6 (2.7, 8.4) | 2.6 (0.6, 4.5) | 0.20 (0.015, 0.85) *‡ | 3.2 (0.5, 5.8) | 7.1 (3.9, 10.3) | 3.7 (1.0, 6.3) | 0.28 (0.034, 0.97) *‡ |
| 14–18 years, female | 0.062 (0, 0.64) *‡ | 16 (11.2, 21.6) | 2.2 (0.5, 4.0) | 0.33 (0.047, 1.1) *‡ | 3.6 (0.7, 6.5) | 10.6 (5.6, 15.6) | 1.3 (0.1, 2.5) * | 4.5 (2.2, 6.8) |
| 19–50 years, male | 0.20 (0.04, 0.61) *‡ | 8.1 (5.5, 10.6) | 3.0 (1.9, 4.1) | 0.25 (0.062, 0.67) *‡ | 8.7 (5.4, 11.9) | 8.0 (5.2, 10.8) | 0.5 (0.1, 1.0) * | 0.9 (0.4, 1.5) |
| 19–50 years, female | 0.28 (0.04, 0.92) *‡ | 25 (20.3, 29.0) | 3.9 (2.4, 5.4) | 0.35 (0.074, 0.99) *‡ | 6.9 (4.3, 9.5) | 12 (8.3, 15.3) | 0.5 (0.1, 0.8) | 6.6 (4.9, 8.3) |
| 51–70 years, male & female | 0.19 (0.018, 0.75) *‡ | 16 (12.6, 19.7) | 6.9 (3.7, 10.1) | 0.32 (0.076, 0.85) *‡ | 6.6 (4.0, 9.2) | 8.4 (5.3, 11.5) | 0.4 (0.1, 0.6) | 4.0 (2.7, 5.3) |
| 71+ years, male & female | 0.27 (0.025, 1.0) *‡ | 15 (11.4, 18.8) | 15 (10.5, 18.7) | 0.10 (0.0020, 0.57) *‡ | 4.3 (2.3, 6.3) | 9.1 (6.7, 11.5) | 0.28 (0.047, 0.88) *‡ | 8.9 (6.2, 11.6) |
| Pregnant or breastfeeding | 1.7 (0.12, 7.0) *‡ | 35 (25.4, 44.8) | 4.5 (2.6, 6.3) | 0.21 (0, 1.8) *‡ | 0.46 (0.047, 1.7) *‡ | 7.3 (2.0, 12.7) | 2.0 (0.12, 8.5) *‡ | 18 (9.9, 25.3) |
Data are from NHANES 2003–2006 representative of the U.S. population, aged ≥9 years, based on biochemical indicators of nutrient deficiency. Values represent percentage at risk of deficiency (99.375% confidence interval). Abbreviations: PLP, pyridoxal-5′-phosphate; MMA, methylmalonic acid; RBC, red blood cell; MCV, mean cell volume. * Relative standard error >30%; ‡ Clopper–Pearson (exact) confidence interval.
Risk of vitamin deficiency or anemia by type of DS reportedly used by survey respondents, according to age, gender and life stage category.
| Not Taking a DS | Taking a DS but Not an FSMV | Taking an FSMV | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % DS Use * | % Deficient † | SE | % DS Use * | % Deficient † | SE | % DS Use * | % Deficient † | SE | ||||
| Entire Dataset | 7281 | 44 | 40 a | 1.3 | 4312 | 40 | 28 b | 1.5 | 1615 | 16 | 14 c | 0.9 |
| Age, gender and life stage category | ||||||||||||
| 9–13 years, male & female | 1321 | 68 | 20 | 1.7 | 260 | 20 | 10 | 2.5 | 150 | 12 | 18 | 4.5 |
| 14–18 years, male | 1007 | 75 | 23 | 2.1 | 182 | 20 | 14 | 3.9 | 52 | 4.8 | 12 | 6.0 |
| 14–18 years, female | 861 | 69 | 37 a | 2.8 | 194 | 25 | 25 ab | 3.7 | 50 | 6.2 | 13 b | 6.2 |
| 19–50 years, male | 1469 | 52 | 33 a | 1.8 | 740 | 36 | 17 b | 2.1 | 232 | 12 | 7.9 b | 1.7 |
| 19–50 years, female | 1138 | 43 | 54 a | 2.0 | 828 | 47 | 35 b | 2.0 | 182 | 10 | 19 b | 2.9 |
| 51–70 years, male & female | 869 | 30 | 47 a | 3.1 | 957 | 44 | 29 b | 2.0 | 515 | 26 | 13 c | 1.5 |
| 71+ years, male & female | 459 | 25 | 58 a | 3.5 | 731 | 49 | 34 b | 2.2 | 348 | 26 | 17 c | 2.5 |
| Pregnant or breastfeeding | 157 | 26 | 55 | 7.3 | 420 | 63 | 46 | 4.5 | 86 | 11 | 34 | 7.4 |
Data are from NHANES 2003–2006 representative of the U.S. population, aged ≥9 years, based on biochemical indicators of nutrient deficiency. Abbreviations: DS, dietary supplement; FSMV, full-spectrum multivitamin-multimineral supplement containing 12 or more vitamins and 7 to 16 minerals. * Percentage of participants in indicated DS use category, representative of the U.S. population, aged ≥9 years. † Deficiency prevalence, based on vitamins A, B6, B12, C, D, E, folate, or anemia. Different superscripts represent significant differences between DS categories within one category of inadequate status, p < 0.0167 using Bonferroni correction for three comparisons and alpha = 0.05.
Figure 1Risk of biochemical vitamin deficiency or anemia, by DS use and dietary vitamin/mineral inadequacy/insufficiency. Dietary inadequacy score reflects the combined number of vitamins and/or minerals for which intake is below the (A) Estimated Average Requirement (EAR) or (B) Recommended Dietary Allowance (RDA) for vitamins A, B6, B12, C, E, folate, and the mineral iron. Proportions are a percentage of the US population at risk of deficiency in one or more vitamin or with anemia according to biochemical measurements of nutritional status, and error bars reflect the SE. NHANES, National Health and Nutrition Examination Survey; DS, dietary supplement; FSMV, full-spectrum multivitamin-multimineral supplement containing 12 or more vitamins and 7 to 16 minerals.